A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
Status:
Withdrawn
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of healthy male and
female subjects with intravenous (IV) infusions of AVI 7537 compared to matched placebo in
and to evaluate the pharmacokinetics (PK).